2610. Home Administration of Intranasal Live Attenuated Influenza Vaccine: A Review of Current Evidence and Potential for Meeting Vaccination Targets

BACKGROUND: During the 2010–2021 influenza seasons, vaccination coverage was below the 70% target for the United States at 33.4–58.6% among children and 50.2% among adults.[1, 2] The live attenuated influenza vaccine (LAIV) is currently approved for healthcare professional administration (HCPA); how...

Descripción completa

Detalles Bibliográficos
Autores principales: Jhaveri, Ravi, Zahn, Matt, Bandell, Allyn R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677229/
http://dx.doi.org/10.1093/ofid/ofad500.2224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677229/
http://dx.doi.org/10.1093/ofid/ofad500.2224

Ejemplares similares